(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MAXCAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

MAXCAR

ST13

US500000090438486

Class

42

Filing

90438486

Registration

6656787

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

03/01/2022

Classification

Registered

Trademark type

Combined

Nice classes

42

Filing date

12/31/2020

Registration date

03/01/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/01/2022

Last transaction

03/01/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

02/03/2020

First use in commerce

09/24/2020

Drawing code

5

Owner type

03

Owner location

Taipei City, TW

Examiner

SCHMIDT, JOHN

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "MaxCAR".

Holders and representatives

Holders

ARCE THERAPEUTICS, INC.

Representatives

Zhi Dong HAMRE, SCHUMANN, MUELLER & LARSON, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Biological research; conducting clinical trials for others; medical research; platform as a service (PAAS) featuring cell bioprocess platforms in the nature of computer software platforms for gene modified immune cells as therapeutic agents; research and development of new products for others; scientific laboratory services; scientific research in the field of cancersautoimmune diseasesinflammatory diseasesneurodegenerative diseasesimmunotherapy; software as a service (SAAS) services featuring software for governing machineries for cell bioprocessing

Publications

History of USPTO decisions and trademark events.

14 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/01/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/14/2021

PUBO

PUBLISHED FOR OPPOSITION

12/14/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/24/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/08/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/08/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/07/2021

GNRT

NON-FINAL ACTION E-MAILED

07/07/2021

CNRT

NON-FINAL ACTION WRITTEN

07/07/2021

DOCK

ASSIGNED TO EXAMINER

07/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/28/2021

NWAP

NEW APPLICATION ENTERED

01/04/2021

Continuous trademark protection

Get notified about every new filing that threatens MAXCAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.